|
|
| October 24, 2008 |
Date of Release of Second Quarter & First Half Financial Results for the Year Ending 31 March 2009. |
| October 14, 2008 |
Biosensors' Drug-Eluting Stent Demonstrates Superior Strut Coverage to Industry Leading Drug-Eluting Stent. |
| October 13, 2008 |
Biosensors' Drug-Eluting Stent Continues to Show Comparable Safety & Efficacy to Industry Leading Drug-Eluting Stent & Outperforms Control Device in Sub-Study. |
| October 2, 2008 |
Biosensors Announces Closure of Netherlands-based Manufacturing Subsidiary. |
| September 30, 2008 |
Biosensors Reports Lapse of Agreement to Acquire Additional 50 Percent of JW Medical Systems from Shandong Weigao. |
| September 22, 2008 |
Biosensors Comments on Recent Articles & Related Litigation. |
| September 2, 2008 |
Analyst Conference Call to Discuss Results of LEADERS Clinical Trial. |
| September 1, 2008 |
Biosensors DES Demonstrates Equivalent Safety & Efficacy to Industry Leading DES in First 'Real World, All Comers; Clinical Study. |
| August 12, 2008 |
Biosensors Reports Record Product Revenues & Strong Sales of BioMatrix® Drug-Eluting Stents in First Fiscal Quarter. |
| July 21, 2008 |
Biosensors Announces Appointment of Dr. Jack Wang as Chief Operating Officer. |
| April 22, 2008 |
Biosensors & Terumo Amend Terms of License Agreement. |
| April 3, 2008 |
Biosensors Launches BioMatrix® Drug-Eluting Stent Across Europe. |
| March 3, 2008 |
Biosensors Announces Start of Enrollment in Beacon II Drug-Eluting Stent Registry. |
| February 18, 2008 |
First Live Implants of BioMatrix® Drug-Eluting Stent in Europe Following CE Mark Approval. |
| January 30, 2008 |
Date of Announcement of Financial Results for Third Quarter of Fiscal Year Ended 31 December 2007. |
| January 24, 2008 |
Biosensors Announces Appointment of Michael Kleine as President & CEO. |
| January 18, 2008 |
Biosensors Receives CE Mark Approval for its BioMatrix® Drug-Eluting Coronary Stent System. |
| January 2, 2008 |
Incorporation of New Subsidiary in India. |
